U.S. E-PRESCRIBING MARKET WAS VALUED AT USD 399.59 MILLION IN 2021 AND IS EXPECTED TO REACH USD 1234.27 MILLION BY 2027, GROWING AT A CAGR OF 20.68% DURING THE YEAR 2022-2027

U.S. E-Prescribing Market Size, Share, & Trends Analysis Report by Type (Standard E-prescribing, and EPCS), Delivery Mode (Web & Cloud-Based, and On-Premises and Desktop), Modality (Integrated, and Standalone), Medication Type (Cardiovascular, Oncology, Anti-Infectives, Behavioural and Mental Health, Pain Medication, and Others), End-user (Healthcare facilities, EHR, Telehealth & Pharmacy Software Vendors, Independent and Speciality Pharmacies, and Pharmacy benefit managers (PBM) and Payors); Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022–2027.

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

188 Pages

icon-table

45 Tables

icon-chart

85 Charts

icon-region

1 Regions

icon-country

1 Countries

icon-company

30 Companies

icon-market

5 Market Segment

U.S. E-PRESCRIBING MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 1234.27 MILLION (2027)
CAGR (REVENUE) 20.68% (2022-2027)
BASE YEAR 2021
FORECAST PERIOD 2022 – 2027
MARKET SEGMENTS Type (Standard E-prescribing, and EPCS), Delivery Mode (Web & Cloud-Based, and On-Premises and Desktop), Modality (Integrated, and Standalone), Medication Type (Cardiovascular, Oncology, Anti-Infectives, Behavioural and Mental Health, Pain Medication, and Others), and End-user (Healthcare facilities, EHR, Telehealth & Pharmacy Software Vendors, Independent and Speciality Pharmacies, Pharmacy benefit managers (PBM) and Payors)
GEOGRAPHICAL ANALYSIS U.S.

U.S. E-PRESCRIBING INDUSTRY INSIGHTS 

The U.S. E-prescribing market size was valued at USD 399.59 million in 2021 and is expected to reach USD 1,234.27 million by 2027, growing at a CAGR of 20.68%. E-prescribing uses healthcare technologies to improve prescription accuracy, enhance patient safety, and ensure cost savings. Also, e-prescribing allows real-time, secure, and bi-directional electronic connectivity between prescribers and pharmacies. 

Telehealth in the country is also growing rapidly as healthcare providers are implementing more sophisticated health IT infrastructures. The rise in third-party vendors offering add-on telehealth services and advancing practice management tools are allowing to integrate more consults into providers’ workflow, and these advancements will boost the e-prescribing services in the market. 

SNIPPETS 

  • Rising concerns over medication and prescription errors resulting in drug overdose deaths are driving the demand for electronic prescribing, accelerating the growth of the U.S. E-prescribing market. 
  • High adoption of EHRs and the launch of new government initiatives and incentive policies are creating opportunities for emerging players, thereby driving the growth of the market. 
  • EHR, telehealth & pharmacy software vendors accounted for a significant share in the end-user segment and are expected to have the highest incremental growth of USD 602.13 million during the forecast period. 
  • Vendors are offering low-cost e-prescribing solutions with advanced features, such as electronic prior authorization and clinical decision support, to meet the requirements of various end-users. 

U.S. E-PRESCRIBING MARKET SEGMENTATION 

This research report includes a detailed segmentation by: 

  • Type 
  • Delivery Mode 
  • Modality 
  • Medication Type 
  • End-user 

SEGMENTATION ANALYSIS 

  • In the e-prescribing market , electronic prescribing of medications has become one of the core functions of EHR that has been available for decades and is mainly used in acute care. Over the same period, other forms of HIT, including prescription monitoring programs and disease registries, began to be more widely deployed. 
  • The EPCS technology can enable healthcare providers to directly integrate opioid prescription information into EHRs, which can improve patient safety, help prevent diversion, fraud, and the ECPS systems can streamline clinician workflow and reduce patient burden. 
  • Cloud-based technologies have become one of the critical tools for healthcare IT initiatives. They are enabling the ability to access healthcare data from different locations and across multiple devices. It can also access and process patients' electronic health records, view diagnostic images in various resolutions or collect health data from patients. 
  • The integrated e-prescribing segment provides greater efficiency and more functions for e-prescribing applications and EHR system that offers more scalability and deploys in a relatively shorter time frame, and it has the fastest growth rate with a CAGR of around 21.12%. 
  • Health information technologies are opening many new frontiers and possibilities in cardiology. By leveraging technologies, several companies have emerged to provide hospitals with the opportunity to adopt EHRs within a healthcare platform. 

VENDOR ANALYSIS 

  • Several U.S. EHR market vendors are integrating e-prescribing services into their EHR software to attract the attention of end-users utilizing the EHR services. These vendors are focusing on providing integrated e-prescribing services, contributing to the major share. 
  • Players who have significantly contributed to the growth of the US e-prescribing market are Surescripts, DrFirst, Practice Fusion, and Insync Healthcare Solutions. However, the industry is expected to experience high growth and competition due to the growing small- and mid-size players collaborating with the technology providers to promote their e-prescribing solutions. 
  • With the increase in the adoption of e-prescribing solutions across various regions, players offering e-prescribing solutions will increase the competitiveness. thereby, the United States e-prescribing market has a high potential for growth with moderate rivalry amongst existing players. 
  • Due to the rapid evolution of e-prescribing, rules, and an influx of new compliance standards and regulations, EHR vendors must consider the advantages of outsourcing their e-prescribing functions to lighten their R&D burdens. EHR vendors would benefit from outsourcing their e-prescribing software development requirements to third parties. 

The U.S. e-prescribing market report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments: 

By Type 

  • Standard E-prescribing 
  • EPCS (Electronic prescribing of controlled substances) 

By Delivery Mode 

  • Web and Cloud-Based 
  • On-Premises and Desktop 

By Modality 

  • Integrated 
  • Standalone 

By Medication Type 

  • Cardiovascular 
  • Oncology 
  • Anti-Infectives 
  • Behavioral and Mental Health 
  • Pain Medication 
  • Others 

By End-User 

  • Healthcare facilities 
  • EHR, Telehealth & pharmacy software vendors 
  • Independent and Speciality Pharmacies 
  • Pharmacy benefit managers (PBM) and Payors 

 

Frequently Asked Questions

How big is the U.S. e-prescribing market?

The U.S. e-prescribing market was valued at USD 399.59 million in 2021 and is expected to reach USD 1234.27 million by 2027.

What are the factors driving the U.S. e-prescribing market?

Low cost, accessibility, value-based care model, financial incentives, innovation, health care efficiency, improved communication between providers, payers, and patients are some of the factors driving the U.S. e-prescribing market.

Who are the key players in the e-prescribing market in the U.S.?

Key Players include Athenahealth, Cerner Corporation, DrFirst, Henry Schein, Inc., InSync Healthcare Solutions, Practice Fusion Inc., Surescripts.

Who are the end-users in the e-prescribing market in the U.S.?

Healthcare facilities, EHR, telehealth & pharmacy software vendors, independent specialty pharmacies, and PBM & payors are the key end-users in the e-prescribing market in the U.S.

Which segment has the highest share in the U.S. e-prescribing market?

Based on type, the standard e-prescribing segment accounted for the major share of 92.82% in 2021 and is anticipated to retain its market dominance during the forecast period.

Download Free Sample

The U.S. e-prescribing market by revenue is expected to grow at a CAGR of 20.68% during the period 2022–2027.

  • Investment in Digital Health & uptake of Telehealth Services in the US
  • Eradicate Prescription Errors & Develop Indication-Based E-Prescribing Solutions
  • Fueling EHR Innovation by Outsourcing e-Prescribing Development
  • Advancements In E-Prescribing Solutions
  • Increasing Focus to Reduce & Monitor Controlled Substances
  • Government Initiative & Incentive Programs for Adopting E-Prescribing
  • Automation of clinical support decision coupled with reduction of manual prescription-associated errors

Base Year: 2021

Forecast year: 2022-2027

The report considers the present scenario of the U.S. e-prescribing market and its market dynamics for the period 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply side of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.

Prominent Vendors

  • Athenahealth
    • Business Overview
    • Product offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Cerner Corporation
  • DrFirst
  • Henry Schein Inc.
  • InSync Healthcare Solutions
  • Practice Fusion Inc.
  • Surescripts

Other Prominent Vendors

  • AdvancedMD
    • Business Overview
    • Product offerings
  • Aegis Healthcare
  • Allscripts Healthcare
  • Bizmatics
  • Bravado Health
  • CareCloud
  • Change Healthcare
  • Chetu
  • Credible
  • Daw Systems
  • DoseSpot
  • Dr. Chrono
  • eClinicalWork
  • eMDs
  • Kareo
  • MD Toolbox
  • Medical Information Technology Inc
  • NextGen Healthcare
  • RXNT
  • SISGAIN
  • Streamline Healthcare Solutions
  • TenEleven Group
  • WebPT

Market Segmentation by Type

  • Standard E-prescribing
  • EPCS (Electronic prescribing of controlled substances)

Market Segmentation by Delivery Mode

  • Web and Cloud-Based
  • On-Premises and Desktop

Market Segmentation by Modality

  • Integrated
  • Standalone

Market Segmentation by Medication Type

  • Cardiovascular
  • Oncology
  • Anti-Infectives
  • Behavioural and Mental Health
  • Pain Medication
  • Others

Market Segmentation by End-User

  • Healthcare facilities
  • EHR, Telehealth & pharmacy software vendors
  • Independent and Speciality Pharmacies
  • Pharmacy benefit managers (PBM) and Payors

1            Research Methodology

2            Research Objectives

3            Research Process

 

4            Scope & Coverage

4.1         Market Definition

4.1.1     Inclusions

4.1.2     Exclusions

4.1.3     Market Estimation Caveats

4.2         Base Year

4.3         Scope Of The Study

 

5            Report Assumptions & Caveats

5.1         Key Caveats

5.2         Currency Conversion

5.3         Market Derivation

 

6            Market at a Glance

7            Introduction

7.1         Overview

7.1.1     Features Of An Ideal Electronic Prescribing System

7.1.2     Standards For Electronic Prescription Systems

7.1.3     Covid-19 Impact On E-Prescribing In US

 

8            Market Opportunities & Trends

8.1         Investment In Digital Health & Uptake Of Telehealth Services

8.2         AI To Eradicate Prescription Errors & Develop Indication-Based Prescribing Systems

8.3         Fueling EHR Innovation By Outsourcing E-Prescribing

8.4         Advancements In E-Prescribing Solutions

 

9            Market Growth Enablers

9.1         Monitoring Use Of Controlled Substances

9.2         Government Initiatives & Incentive Programs For Adopting E-Prescribing

9.3         Automating Clinical Support Decisions & Reducing Manual Prescription Errors

 

10          Market Growth Restraints

10.1       High Cost Of Deployment & Inadequate Security Concerns

10.2       Incompatible Software Systems & Complex Technologies

10.3       Absence Of Standardized Competence Leading To E-Formulary Errors

 

11          Market Landscape

11.1       Market Overview

11.2       Market Size & Forecast

11.2.1   E-prescribing Type

11.2.2   Delivery Mode

11.2.3   Modality

11.2.4   Medication

11.2.5   End-users

11.3       FIVE FORCES ANALYSIS

11.3.1   Threat of New Entrants

11.3.2   Bargaining Power of Suppliers

11.3.3   Bargaining Power of Buyers

11.3.4   Threat of Substitutes

11.3.5   Competitive Rivalry

 

12          Type

12.1       Market Snapshot & Growth Engine

12.2       Market Overview

12.3       Standard E-Prescribing

12.3.1   Market Overview

12.3.2   Market Size & Forecast

12.4       EPCS

12.4.1   Market Overview

12.4.2   Market Size & Forecast

 

13          Delivery Mode

13.1       Market Snapshot & Growth Engine

13.2       Market Overview

13.3       Web- & Cloud-Based

13.3.1   Market Overview

13.3.2   Market Size & Forecast

13.4       On-Premise & Desktop

13.4.1   Market Overview

13.4.2   Market Size & Forecast

 

14          Modality

14.1       Market Snapshot & Growth Engine

14.2       Market Overview

14.3       Integrated

14.3.1   Market Overview

14.3.2   Market Size & Forecast

14.4       Standalone

14.4.1   Market Overview

14.4.2   Market Size & Forecast

 

15          Medication Type

15.1       Market Snapshot & Growth Engine

15.2       Market Overview

15.3       Cardiovascular

15.3.1   Market Overview

15.3.2   Market Size & Forecast

15.4       Oncology

15.4.1   Market Overview

15.4.2   Market Size & Forecast

15.5       Anti-Infectives

15.5.1   Market Overview

15.5.2   Market Size & Forecast

15.6       Behavioral & Mental Health

15.6.1   Market Overview

15.6.2   Market Size & Forecast

15.7       Pain Medication

15.7.1   Market Overview

15.7.2   Market Size & Forecast

15.8       Others

15.8.1   Market Overview

15.8.2   Market Size & Forecast

 

16          End-User

16.1       Market Snapshot & Growth Engine

16.2       Market Overview

16.3       Healthcare Facilities

16.3.1   Market Overview

16.3.2   Market Size & Forecast

16.4       EHR, Telehealth, & Pharmacy Software Vendors

16.4.1   Market Overview

16.4.2   Market Size & Forecast

16.5       Independent & Specialty Pharmacies

16.5.1   Market Overview

16.5.2   Market Size & Forecast

16.6       PBM & Payors

16.6.1   Market Overview

16.6.2   Market Size & Forecast

 

17          Competitive Landscape

17.1       Competition Overview

17.2       Market Share Analysis

17.2.1   Surescripts in E-prescribing Market

17.2.2   DrFirst in E-prescribing Market

17.2.3   Practice Fusion in E-prescribing Market

17.2.4   InSync Healthcare Solutions in E-prescribing Market

 

18          Key Company Profiles

18.1       ATHENAHEALTH

18.1.1   Business Overview

18.1.2   Product Offerings

18.1.3   Key Strategies

18.1.4   Key Strengths

18.1.5   Key Opportunities

18.2       CERNER CORPORATION

18.2.1   Business Overview

18.2.2   Product Offerings

18.2.3   Key Strategies

18.2.4   Key Strengths

18.2.5   Key Opportunities

18.3       DRFIRST

18.3.1   Business Overview

18.3.2   Product Offerings

18.3.3   Key Strategies

18.3.4   Key Strengths

18.3.5   Key Opportunities

18.4       HENRY SCHEIN INC.

18.4.1   Business Overview

18.4.2   Product Offerings

18.4.3   Key Strategies

18.4.4   Key Strengths

18.4.5   Key Opportunities

18.5       INSYNC HEALTHCARE SOLUTIONS

18.5.1   Business Overview

18.5.2   Product Offerings

18.5.3   Key Strategies

18.5.4   Key Strengths

18.5.5   Key Opportunities

18.6       PRACTICE FUSION

18.6.1   Business Overview

18.6.2   Product Offerings

18.6.3   Key Strategies

18.6.4   Key Strengths

18.6.5   Key Opportunities

18.7       SURESCRIPTS

18.7.1   Business Overview

18.7.2   Product Offerings

18.7.3   Key Strategies

18.7.4   Key Strengths

18.7.5   Key Opportunities

 

19          Other Prominent Vendors

19.1       ADVANCEDMD

19.1.1   Business Overview

19.1.2   Product Offerings

19.2       AEGIS HEALTHCARE

19.2.1   Business Overview

19.2.2   Product Offerings

19.3       ALLSCRIPTS HEALTHCARE

19.3.1   Business Overview

19.3.2   Product Offerings

19.4       BIZMATICS

19.4.1   Business Overview

19.4.2   Product Offerings

19.5       BRAVADO HEALTH

19.5.1   Business Overview

19.5.2   Product Offerings

19.6       CARECLOUD

19.6.1   Business Overview

19.6.2   Product Offerings

19.7       CHANGE HEALTHCARE

19.7.1   Business Overview

19.7.2   Product Offerings

19.8       CHETU

19.8.1   Business Overview

19.8.2   Product Offerings

19.9       CREDIBLE

19.9.1   Business Overview

19.9.2   Product Offerings

19.10    DAW SYSTEMS

19.10.1 Business Overview

19.10.2 Product Offerings

19.11    DOSESPOT

19.11.1 Business Overview

19.11.2 Product Offerings

19.12    DRCHRONO

19.12.1 Business Overview

19.12.2 Product Offerings

19.13    ECLINICALWORKS

19.13.1 Business Overview

19.13.2 Product Offerings

19.14    EMDS

19.14.1 Business Overview

19.14.2 Product Offerings

19.15    KAREO

19.15.1 Business Overview

19.15.2 Product Offerings

19.16    MDTOOLBOX

19.16.1 Business Overview

19.16.2 Product Offerings

19.17    MEDICAL INFORMATION TECHNOLOGY INC.

19.17.1 Business Overview

19.17.2 Product Offerings

19.18    NEXTGEN HEALTHCARE

19.18.1 Business Overview

19.18.2 Product Offerings

19.19    RXNT

19.19.1 Business Overview

19.19.2 Product Offerings

19.20    SISGAIN

19.20.1 Business Overview

19.20.2 Product Offerings

19.21    STREAMLINE HEALTHCARE SOLUTIONS

19.21.1 Business Overview

19.21.2 Product Offerings

19.22    TENELEVEN GROUP

19.22.1 Business Overview

19.22.2 Product Offerings

19.23    WEBPT

19.23.1 Business Overview

19.23.2 Product Offerings

 

20          Report Summary

20.1       Key Takeaways

20.2       Strategic Recommendations

 

21          Quantitative Summary

21.1       Market By Type

21.2       Market By Delivery Mode

21.3       Market By Modality

21.4       Market By Medication Type

21.5       Market By End-User

 

22          Appendix

22.1       Abbreviations

LIST OF EXHIBITS            

Exhibit 1             Segmentation of US E-prescribing Market

Exhibit 2             US E-prescribing Market Size Calculation Approach 2021

Exhibit 3             Graduated Levels of Electronic Prescribing

Exhibit 4             Impact of Investment in Digital Health & Uptake of Telehealth Services

Exhibit 5             Impact of AI to Eradicate Prescription Errors & Develop Indication-based Prescribing Systems

Exhibit 6             Impact of Fueling EHR Innovation by Outsourcing E-prescribing

Exhibit 7             EHR Adoption Rate in US (%)

Exhibit 8             Impact of Advancements in E-prescribing Solutions

Exhibit 9             EHR to E-prescribing: Timeline of Development

Exhibit 10           Evolution of E-prescribing

Exhibit 11           Impact of Monitoring Use of Controlled Substances

Exhibit 12           Electronic Prescribing of Controlled Substances: Statistics

Exhibit 13           Impact of Government Initiatives & Incentive Programs for Adopting E-prescribing

Exhibit 14           Impact of Automation of Clinical Support Decision & Reducing Manual Prescription Errors

Exhibit 15           Impact of High Cost of Deployment & Inadequate Security Concerns

Exhibit 16           Impact of Incompatible Software Systems & Complex Technologies

Exhibit 17           Impact of Absence of Standardized Competence Leading to E-formulary Errors

Exhibit 18           US E-prescribing Market 2021–2027 ($ million)

Exhibit 19           US E-prescribing Market by Type

Exhibit 20           US E-prescribing Market by Delivery Mode

Exhibit 21           US E-prescribing Market by Modality

Exhibit 22           US E-prescribing Market by Medication Type

Exhibit 23           US E-prescribing Market by End-user

Exhibit 24           Five Forces Analysis 2021

Exhibit 25           Incremental Growth by Type 2021 & 2027

Exhibit 26           US E-prescribing Market by Type

Exhibit 27           US E-prescribing Market by Type: Incremental Growth

Exhibit 28           US E-prescribing Market by Type: Absolute Growth

Exhibit 29           Number of E-prescriptions by Surescripts (billion)

Exhibit 30           US Standard E-prescribing Market: Incremental & Absolute Growth

Exhibit 31           E-prescribing by Pharmacies & Prescribers (%)

Exhibit 32           US Standard E-prescribing Market 2021–2027 ($ million)

Exhibit 33           Surescripts Generated E-prescribing for Controlled Substances (million)

Exhibit 34           E-prescribing for Controlled Substances by Pharmacies & Prescribers (%)

Exhibit 35           US EPCS E-prescribing Market: Incremental & Absolute Growth

Exhibit 36           US EPCS E-prescribing Market 2021–2027 ($ million)

Exhibit 37           Incremental Growth by Delivery Mode 2021 & 2027

Exhibit 38           US E-prescribing Market by Delivery Mode

Exhibit 39           US E-prescribing Market by Delivery Mode: Incremental Growth

Exhibit 40           US E-prescribing Market by Delivery Mode: Absolute Growth

Exhibit 41           US Web- & Cloud-based E-prescribing Market: Incremental & Absolute Growth

Exhibit 42           US Web- & Cloud-based E-prescribing Market 2021–2027 ($ million)

Exhibit 43           US On-premise & Desktop E-prescribing Market: Incremental & Absolute Growth

Exhibit 44           US On-premise & Desktop E-prescribing Market 2021–2027 ($ million)

Exhibit 45           Incremental Growth by Modality 2021 & 2027

Exhibit 46           US E-prescribing Market by Modality

Exhibit 47           US Modality E-prescribing Market: Incremental Growth

Exhibit 48           US Modality E-prescribing Market: Absolute Growth

Exhibit 49           US Integrated Modality E-prescribing Market: Incremental & Absolute Growth

Exhibit 50           US Integrated E-prescribing Market 2021–2027 ($ million)

Exhibit 51           US Standalone E-prescribing Market: Incremental & Absolute Growth

Exhibit 52           US Standalone E-prescribing Market 2021–2027 ($ million)

Exhibit 53           Incremental Growth by Medication Type 2021 & 2027

Exhibit 54           US E-prescribing Market by Medication Type

Exhibit 55           E-prescribing Usage in Various Classes of Medication (%)

Exhibit 56           Top Five Specialties Using EPCS (2019)

Exhibit 57           US E-prescribing Market by Medication Type: Incremental Growth

Exhibit 58           US E-prescribing Market by Medication Type: Absolute Growth

Exhibit 59           US Cardiovascular E-prescribing Market: Incremental & Absolute Growth

Exhibit 60           US Cardiovascular E-prescribing Market 2021–2027 ($ million)

Exhibit 61           US Oncology E-prescribing Market: Incremental & Absolute Growth

Exhibit 62           US Oncology E-prescribing Market 2021–2027 ($ million)

Exhibit 63           US Anti-infectives E-prescribing Market: Incremental & Absolute Growth

Exhibit 64           US Anti-infectives E-prescribing Market 2021–2027 ($ million)

Exhibit 65           US Behavioral & Mental Health E-prescribing Market: Incremental & Absolute Growth

Exhibit 66           US Behavioral & Mental Health E-prescribing Market 2021–2027 ($ million)

Exhibit 67           E-prescribing Opioids by Surescripts in US (million)

Exhibit 68           Top Five Opioid E-prescription by Surescripts (2019)

Exhibit 69           US Pain Medication E-prescribing Market: Incremental & Absolute Growth

Exhibit 70           US Pain Medication E-prescribing Market 2021–2027 ($ million)

Exhibit 71           US Other E-prescribing Market: Incremental & Absolute Growth

Exhibit 72           US Other E-prescribing Market 2021–2027 ($ million)

Exhibit 73           Incremental Growth by End-user 2021 & 2027

Exhibit 74           US E-prescribing Market by End user

Exhibit 75           US End-user E-prescribing Market: Incremental Growth

Exhibit 76           US End-user E-prescribing Market: Absolute Growth

Exhibit 77           US Healthcare Facilities E-prescribing Market: Incremental & Absolute Growth

Exhibit 78           US Healthcare Facilities E-prescribing Market 2021–2027 ($ million)

Exhibit 79           US EHR, Telehealth, & Pharmacy Software Vendors E-prescribing Market: Incremental & Absolute Growth

Exhibit 80           US EHR, Telehealth, & Pharmacy Software Vendors E-prescribing Market 2021–2027 ($ million)

Exhibit 81           E-prescribing Specialty Drugs as Percentage of Total Drug Spend

Exhibit 82           US Independent & Specialty Pharmacies E-prescribing Market: Incremental & Absolute Growth

Exhibit 83           US Independent & Specialty Pharmacies E-prescribing Market 2021–2027 ($ million)

Exhibit 84           US PBM & Payors E-prescribing Market: Incremental & Absolute Growth

Exhibit 85           US PBM & Payors E-prescribing Market 2021–2027 ($ million)        

             

LIST OF TABLES

Table 1                Key Caveats

Table 2                Currency Conversion 2015−2021

Table 3                Cost Associated with Basic E-prescribing & EPCS in EHRs

Table 4                Consequences of E-prescribing Errors

Table 5                Pros & Cons of Standalone & Integrated E-prescribing Solutions

Table 6                Athenahealth: Major Product Offerings

Table 7                Cerner Corporation: Major Product Offerings

Table 8                DrFirst: Major Product Offerings

Table 9                Henry Schein Inc.: Major Product Offerings

Table 10              InSync Healthcare Solutions: Major Product Offerings

Table 11              Practice Fusion: Major Product Offerings

Table 12              Surescripts: Major Product Offerings

Table 13              AdvancedMD: Major Product Offerings

Table 14              Aegis Healthcare: Major Product Offerings

Table 15              Allscripts Healthcare: Major Product Offerings

Table 16              Bizmatics: Major Product Offerings

Table 17              Bravado Health: Major Product Offerings

Table 18              CareCloud: Major Product Offerings

Table 19              Change Healthcare: Major Product Offerings

Table 20              Chetu: Major Product Offerings

Table 21              Credible: Major Product Offerings

Table 22              Daw Systems: Major Product Offerings

Table 23              DoseSpot: Major Product Offerings

Table 24              DrChrono: Major Product Offerings

Table 25              eClinicalWorks: Major Product Offerings

Table 26              eMDs: Major Product Offerings

Table 27              Kareo: Major Product Offerings

Table 28              MDToolbox: Major Product Offerings

Table 29              Medical Information Technology Inc.: Major Product Offerings

Table 30              NextGen Healthcare: Major Product Offerings

Table 31              RXNT: Major Product Offerings

Table 32              SISGAIN: Major Product Offerings

Table 33              Streamline Healthcare Solutions: Major Product Offerings

Table 34              TenEleven Group: Major Product Offerings

Table 35              WebPT: Major Product Offerings

Table 36              US E-prescribing Market by Type 2021–2027 ($ million)

Table 37              US E-prescribing Market by Type 2021–2027 (%)

Table 38              US E-prescribing Market by Delivery Mode 2021–2027 ($ million)

Table 39              US E-prescribing Market by Delivery Mode 2021–2027 (%)

Table 40              US E-prescribing Market by Modality 2021–2027 ($ million)

Table 41              US E-prescribing Market by Modality 2021–2027 (%)

Table 42              US E-prescribing Market by Medication Type 2021–2027 ($ million)

Table 43              US E-prescribing Market by Medication Type 2021–2027 (%)

Table 44              US E-prescribing Market by End-user 2021–2027 ($ million)

Table 45              US E-prescribing Market by End-user 2021–2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$4500.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date